Traws Pharma (TRAW) Misses Q2 EPS by 11c

Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.

For earnings history and earnings-related data on Traws Pharma (TRAW) click here.

You May Also Be Interested In

• Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
• Barclays Reinstates EQT AB (EQT:SS) (EQBBF) at Equalweight
• Blue Star Gold closes final tranche of flow-through private placement